Justice Samuel Alito extended a freeze on restrictions for mifepristone mail-order prescribing, keeping the Biden-era teleprescribing policy in place through 5 p.m. Thursday, according to Axios. The extension came in response to requests from drugmakers Danco Laboratories and GenBioPro, who asked the Court to restore mail and telehealth access to the pill while litigation continues.